Microbix Biosystems Inc. (TSX:MBX)
Canada · Delayed Price · Currency is CAD 0.3000
+0.0100 (3.45%)
Aug 10, 2026, 3:20 PM EST
Microbix Biosystems Market Cap
Microbix Biosystems has a market cap or net worth of CAD 39.95 million as of August 10, 2026. Its market cap has increased by 0.11% in one year.
Market Cap
39.95M
Enterprise Value
38.62M
Revenue
14.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.30
ChartMarket Cap Chart
Since October 1, 1992, Microbix Biosystems's market cap has increased from 13.38M to 39.95M, an increase of 198.55%. That is a compound annual growth rate of 3.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 39.95M | 24.98% |
| Dec 31, 2025 | 31.97M | -41.99% |
| Dec 31, 2024 | 55.10M | 3.47% |
| Dec 29, 2023 | 53.25M | -6.55% |
| Dec 30, 2022 | 56.99M | -47.62% |
| Dec 31, 2021 | 108.80M | 135.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NurExone Biologic | 46.06M |
| Onco-Innovations | 44.40M |
| BriaCell Therapeutics | 42.19M |
| MedMira | 42.10M |
| Sernova Biotherapeutics | 41.54M |
| Medicenna Therapeutics | 36.00M |
| Telescope Innovations | 34.76M |
| Resverlogix | 32.66M |